Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-10-04

FDA Approved: COLESEVELAM HCL — Supplemental Application (Ascend Laboratories, LLC)

View source ↗

Summary

The FDA approved a supplemental application for Colesevelam HCl submitted by Ascend Laboratories, LLC, as part of the generic drug approval process. The action …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Colesevelam HCl (colesevelam)

Snippet

SUPPL AP for COLESEVELAM HCL (COLESEVELAM HCL)